In tumour-bearing mice, fludarabine also effectively decreased IDO1 in HCC induced by MV-Edm and adoptive CD8+NKG2D+ cells, leading to an enhanced antitumour immune responses and prolonged survival. Here, IDO1 is linked to hepatocellular carcinoma.